Gavin C. is a seasoned Life Sciences Executive and Strategic Advisor, with a robust background in general management, growth strategy, and portfolio management. They began their career as a Business Analyst at McKinsey & Company from 1996 to 1998, later advancing to engagements as an Engagement Manager and Associate. Gavin worked at Monsanto as a Business Development Associate from 1998 to 2000, followed by a significant tenure at Baxter International Inc., where they held various leadership roles, including SVP of Strategy and President of the Acute Therapies division. Currently, Gavin serves as President of Acute Therapies at Vantive, following its carve-out from Baxter in 2025. They are also pursuing a Bachelor of Arts in Government from Dartmouth College and an MBA from Stanford University Graduate School of Business.
This person is not in any teams
This person is not in any offices